All three models agree that TSLA is primed for a mean-reversion bounce from oversold conditions near the $297.38 support level, supported by a bullish MACD crossover and RSI curling up from the low 30s. Analysts highlight that the recent earnings miss is likely digested, with depressed volume into support suggesting seller exhaustion rather than fresh distribution. Supported by a bullish broader equity regime and relative strength in the Consumer Discretionary sector, the stock is positioned for a relief rally toward resistance levels at $337 or $369 over the next 1-3 weeks.
All three models characterize the current price action as a low-volume counter-trend rally within a structural downtrend, noting that TSLA remains well below its 20-day and 50-day SMAs following a -38.9% Q2 earnings miss. Analysts flag a 'nosebleed' valuation (278x P/E) and razor-thin 3.7% margins as fundamental headwinds that make the stock vulnerable to a rejection at the $337 resistance shelf. One model specifically warns that upside is limited ahead of high-impact US PCE data, which could trigger a risk-off rotation and a retest of the $297.38 52-week low.
TSLA is sitting just above firm support at $297.38 near its 52-week low with RSI at 33 on both the 4h and 1day intervals and a fresh bullish MACD zero-cross on the 4h, marking an oversold mean-reversion setup. The favorable long cohort prior (62.5% shrunk win, median +0.75R, 0% 24h loss) plus a confirmed bullish equity regime and confirming XLY strength support a bounce back toward the $337 resistance / value-area over the next 1-3 weeks. Depressed volume into support suggests seller exhaustion rather than fresh distribution.
TSLA remains in a structural downtrend, trading -37% from its 52-week high and below every major moving average (SMA 20/50 on both daily and 4h) , with a badly missed Q2 earnings (-38.9% EPS surprise) and a nosebleed valuation (P/E 278, 3.7% margin) . The current bounce is a low-volume relief rally into overhead 1-day resistance at $337 and prior HVN cluster near $382- $395; I expect the primary downtrend to reassert, rolling price back toward the $297 low over the next 1-3 weeks. A rejection below the $337 resistance shelf is the mechanism for renewed downside continuation.
TSLA is trading near its 52-week low at $314, just 5.6% above the $297.38 support level, with deeply oversold RSI (33 on both 4h and 1day) that has begun curling up over the last three bars, signaling exhaustion of the selling pressure. The 4h MACD has just printed a bullish zero-cross with a positive histogram, and the rising RSI from oversold territory near a major support level creates a high-probability mean-reversion bounce setup. With the broad equity regime remaining bullish and Consumer Discretionary (XLY) confirming the move, TSLA is positioned for a recovery rally toward the first resistance at $337 over the next 1-3 weeks.
TSLA is in a structural downtrend after a -38.9% Q2 earnings miss on Jul 21, with price trading well below both the 20-day and 50-day SMAs ($364 and $390 respectively). The current bounce from the $297.38 52-week low is a counter-trend rally on depressed volume (12th percentile) that is already overextended on the 30-minute timeframe above the upper Bollinger band, setting up a mean-reversion fade. With a P/E of 278x, razor-thin 3.7% margins, and elevated leverage (D/E 18.37), the fundamental case for further downside remains intact as the earnings damage reprices through the tape.
TSLA is showing signs of a potential reversal from oversold conditions near a critical support level, with improving momentum and a bullish MACD crossover on the 4-hour timeframe. The recent earnings miss has been digested, and the stock is now trading above its 52-week low with RSI rising from deeply oversold territory (33.23 on 4h), suggesting a relief rally could be underway. The broader market regime remains bullish, and TSLA’s sector (Consumer Discretionary) is showing relative strength, which could support a move toward the nearest resistance at $369.01.
TSLA is positioned for a short swing trade due to its technical breakdown and overextension near key resistance levels, coupled with a bearish catalyst regime. The stock has failed to sustain momentum above its 20-day SMA ($332.88 on 4h) and is now retesting the $317.64 resistance level on the 30-minute timeframe, which aligns with the 4h resistance at $369.01. With RSI on the 4h timeframe rising but still below 40 and MACD showing a recent bullish crossover, the upside appears limited and likely to fail into the upcoming US PCE data—a high-impact macro event that could trigger risk-off sentiment. The broader regime is bullish but narrowly led by mega-cap tech, leaving TSLA vulnerable to profit-taking and rotation into defensive sectors.